Effects of Dietary and Behavioral Intervention and Orlistat for Management of Obesity and Metabolic Syndrome on Response to Hepatitis C Therapy.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Orlistat (Primary) ; Antivirals
- Indications Hepatitis C; Obesity
- Focus Pharmacodynamics; Therapeutic Use
- 08 Apr 2009 New trial record